CMS final rule slashes 340B drug payments by $1.6B; Hospitals vow to fight it in court

CMS made dramatic payment cuts to the 340B drug discount program in a final rule released Wednesday, but hospitals plan to fight them in court. Ted Slafsky, CEO of 340B Health said that CMS has taken “unprecedented action that will harm patient care.”

Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive